Protein composition of the vaccinia virus mature virion.
about
Poxvirus membrane biogenesisThe eEF1A Proteins: At the Crossroads of Oncogenesis, Apoptosis, and Viral InfectionsIntracellular Transport of Vaccinia Virus in HeLa Cells Requires WASH-VPEF/FAM21-Retromer Complexes and Recycling Molecules Rab11 and Rab22.Crystal structure of poxvirus thymidylate kinase: An unexpected dimerization has implications for antiviral therapyThe master regulator of the cellular stress response (HSF1) is critical for orthopoxvirus infectionComparison of the Cowpox Virus and Vaccinia Virus Mature Virion Proteome: Analysis of the Species- and Strain-Specific ProteomeGeneration of a complete single-gene knockout bacterial artificial chromosome library of cowpox virus and identification of its essential genesVaccinia viral protein A27 is anchored to the viral membrane via a cooperative interaction with viral membrane protein A17Simultaneous Quantification of Viral Antigen Expression Kinetics Using Data-Independent (DIA) Mass Spectrometry.A novel cellular protein, VPEF, facilitates vaccinia virus penetration into HeLa cells through fluid phase endocytosis.Disulfide bond formation at the C termini of vaccinia virus A26 and A27 proteins does not require viral redox enzymes and suppresses glycosaminoglycan-mediated cell fusion.Proteomic basis of the antibody response to monkeypox virus infection examined in cynomolgus macaques and a comparison to human smallpox vaccination.Human CD4+ T cell epitopes from vaccinia virus induced by vaccination or infectionMembrane remodelling during vaccinia virus morphogenesis.Identification of essential filovirion-associated host factors by serial proteomic analysis and RNAi screen.Human antibody responses to the polyclonal Dryvax vaccine for smallpox prevention can be distinguished from responses to the monoclonal replacement vaccine ACAM2000.Structure/Function analysis of the vaccinia virus F18 phosphoprotein, an abundant core component required for virion maturation and infectivity.Cellular proteins associated with the interior and exterior of vesicular stomatitis virus virionsThe neutralizing antibody response to the vaccinia virus A28 protein is specifically enhanced by its association with the H2 proteinDefinition of epitopes and antigens recognized by vaccinia specific immune responses: their conservation in variola virus sequences, and use as a model system to study complex pathogensParamecium bursaria chlorella virus 1 proteome reveals novel architectural and regulatory features of a giant virus.Host genome integration and giant virus-induced reactivation of the virophage mavirus.Participation of vaccinia virus l2 protein in the formation of crescent membranes and immature virions.Interaction between the G3 and L5 proteins of the vaccinia virus entry-fusion complex.Smallpox vaccines: targets of protective immunity.Crystal structure of vaccinia viral A27 protein reveals a novel structure critical for its function and complex formation with A26 proteinT cell antigen discovery using soluble vaccinia proteome reveals recognition of antigens with both virion and nonvirion association.Measurement of antibody responses to Modified Vaccinia virus Ankara (MVA) and Dryvax(®) using proteome microarrays and development of recombinant protein ELISAsTranscriptional repression and RNA silencing act synergistically to demonstrate the function of the eleventh component of the vaccinia virus entry-fusion complex.An overview of the vaccinia virus infectome: a survey of the proteins of the poxvirus-infected cellVaccinia mature virus fusion regulator A26 protein binds to A16 and G9 proteins of the viral entry fusion complex and dissociates from mature virions at low pHUncovering the interplay between CD8, CD4 and antibody responses to complex pathogens.Integrin β1 mediates vaccinia virus entry through activation of PI3K/Akt signaling.Proteomic analysis of purified Newcastle disease virus particles.Antibody profiling by proteome microarray reveals the immunogenicity of the attenuated smallpox vaccine modified vaccinia virus ankara is comparable to that of Dryvax.Redundancy and plasticity of neutralizing antibody responses are cornerstone attributes of the human immune response to the smallpox vaccine.Vaccinia virus E2L null mutants exhibit a major reduction in extracellular virion formation and virus spread.Humoral immunity to smallpox vaccines and monkeypox virus challenge: proteomic assessment and clinical correlations.Unusual features of vaccinia virus extracellular virion form neutralization resistance revealed in human antibody responses to the smallpox vaccine.Poxviruses Encode a Reticulon-Like Protein that Promotes Membrane Curvature.
P2860
Q26823774-DF97A278-2795-48F5-B510-66672D7D51B0Q26825635-C1E7A92E-02EA-4BDF-A73D-6F5BA8710630Q27321587-125259E1-4C42-4F59-B973-A67759708A0EQ27652695-9433A367-46E1-4E66-AF51-6A24D09DD1DEQ28539622-A2ECED73-D0E8-40CA-AD1F-1B89D8E41603Q28550799-62D4809A-78B8-4207-B3CF-4D16D67FC9A2Q28659589-EE9BA646-416C-48B9-9CE5-89B1FA30AB7AQ30358168-11919242-B216-4D2B-B3B9-414D058C1B34Q30372565-7659AC37-B316-4AAA-9732-9952BF5F7DC6Q30483178-5410899F-F31D-4F64-A592-0F6730092975Q30488301-4F3C7CF1-F2EE-4BD7-9893-4849054B24FCQ30994031-59A9CA39-B447-463B-88F2-DD10078EB3BEQ33302672-5B2F3813-C9E8-465B-B2AA-CCA6D21159AEQ33392279-CD87C3B2-D37C-4F1D-B059-5DB655BF90A6Q33655087-580F9CA4-E5B2-4E32-AF73-56727256C1A8Q33743444-F21EC1EE-7C34-42C9-B77A-C7E5BDEFDA94Q33990733-51325AEE-924C-46D9-A662-8F7CDA847200Q34020589-7603D365-E33D-4ECE-B792-C40413742703Q34039477-E094CB16-2ED7-4E2F-A401-3B86F53A3FA5Q34085985-15566CC1-1D8E-4BB9-95B1-01589E4593FFQ34281427-79F8D250-9A44-4ABA-983B-28881EBA1A5BQ34546849-98133DE2-0DC3-4EBD-A824-32764D533CF0Q34742862-65BB6625-217D-4A91-A877-385614ECC163Q34778139-7AFFEF7B-900F-46E5-9888-2E7EE07CEAF2Q34780607-1E56FBCB-2611-440C-8654-7A6E7C4FCCF0Q34976944-6589A246-1914-47E6-8CF6-93AF4ADBC21CQ35206861-F48CF26E-F098-4211-8587-2069B924EBDBQ35634159-CBFE456B-B8EF-4203-8B11-E2ED59E2030DQ35665944-78E38A00-25E2-4E44-BA40-C4A1FE6ED473Q35689619-E3AE6828-22EF-4BA8-9C64-4C10EFF0CE6BQ35826881-A3ED8CCC-7A5E-4A69-915F-57D0141DE5B3Q35998125-536D4392-9CBB-4213-A10D-A43563F3431FQ36086790-2A9CEB35-786D-4DC8-BF8C-D023BD6B8215Q36146280-E247008F-D660-4EB0-8D61-8A3CF3398DB0Q36424513-07F76D48-085F-4322-8515-B35811EF6218Q36498147-036129DF-69FA-4E7A-A17E-408D00477642Q36540095-68F3371C-3ABF-4248-A2DC-AA8ADA4BDC9EQ36559636-53DD4C25-885F-4567-8A34-9005AA0A7765Q36559797-0AC835F0-D97F-4E8B-A7CE-94F8B8BCAE80Q36669639-4CAA1595-71BC-4E8E-8438-E7E4414CBEC2
P2860
Protein composition of the vaccinia virus mature virion.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Protein composition of the vaccinia virus mature virion.
@en
Protein composition of the vaccinia virus mature virion.
@nl
type
label
Protein composition of the vaccinia virus mature virion.
@en
Protein composition of the vaccinia virus mature virion.
@nl
prefLabel
Protein composition of the vaccinia virus mature virion.
@en
Protein composition of the vaccinia virus mature virion.
@nl
P2093
P1433
P1476
Protein composition of the vaccinia virus mature virion.
@en
P2093
Kim K Hixson
Mary S Lipton
Ronald J Moore
Wolfgang Resch
P304
P356
10.1016/J.VIROL.2006.08.025
P407
P50
P577
2006-09-26T00:00:00Z